Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skymax Laboratories is an Indian pharmaceutical company specializing in the development, manufacture, and export of a wide range of generic pharmaceutical formulations. The company produces various dosage forms, including tablets, capsules, liquid orals, and ointments, covering diverse therapeutic segments such as anti-infectives, analgesics, and cardiovascular health. With a focus on international markets, Skymax operates manufacturing facilities that adhere to global quality standards like WHO-GMP. Their business model centers on providing affordable healthcare solutions through a robust distribution network across Asia, Africa, and Latin America. The company maintains a strong presence in semi-regulated markets, offering a portfolio that includes both acute and chronic care medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skymax Laboratories.